Clinical trial Recruiting at 1 site Interventional Ages 18 to 79

Telerehabilitation program for post-burn recovery

Official title: Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery

Run by The University of Texas Medical Branch, Galveston · NCT06162052 · Data updated 2026-11-12

This study is testing a new online rehabilitation program for burn survivors to see if it helps them recover better than regular physical therapy.

Quick facts

Study typeInterventional
Ages18 Years to 79 Years
SexAll
Enrollment30 (estimated)
SponsorThe University of Texas Medical Branch, Galveston
Academic / other
Locations1 site (Galveston, Texas)
StatusRecruiting
StartedApril 2, 2024
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedMarch 6, 2026
Trial IDNCT06162052 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 79 who have sustained a burn injury affecting a joint and have access to the necessary technology.

Probably not a fit

Patients with medical conditions that increase risk, those participating in other trials, or those without internet access may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the effects of a telerehabilitation program on recovery after a burn injury. It compares a traditional physical therapy approach with a technology-enhanced method that includes a habit-tracking application and virtual therapy sessions. The goal is to improve range of motion and quality of life for burn patients. This pilot study will also assess feasibility, collect preliminary data, and gather patient feedback to inform future research.

Why it matters

Potential benefit: If successful, this program could significantly enhance recovery outcomes for burn patients by improving their physical function and overall quality of life.

How similar studies have gone: While similar telerehabilitation approaches have shown promise in other conditions, this specific application for post-burn recovery is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults: ≥18 to ≤79 years of age
* Not participating in another interventional trial
* Admitted to the Blocker Burn Unit for treatment of initial burn
* Subject is able and willing to follow the protocol requirements
* Burn wound / scar / contracture occurring across at least one joint.
* Has regular access to smart phone, tablet, or computer with internet access.

Exclusion Criteria:

* Any medical condition that, in the opinion of the investigator or physician, would place the subject at increased risk for participation.
* Concurrent participation on another interventional clinical trial
* History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the subject to comply with the study procedures or follow the investigators instructions.
* Patients without internet access.

Where it's running

  • University of Texas Medical Branch
    Galveston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Celeste Finnerty, PhD — University of Texas
  • Study coordinator: Celeste Finnerty, PhD
  • Email: ccfinner@utmb.edu
  • Phone: (409)772-1011

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.